Jon Edwards PhD
General Partner
RQ Bio is a UK-based biotechnology company developing long-acting monoclonal antibodies against seasonal influenza with the goal of providing immediate, powerful, and long-lasting protection against severe viral disease in immunocompromised and high-risk subjects. The company is advancing its lead product RQB01, a long-acting, potent and broadly protective antibody product, through IND-enabling studies.
